18th October 2017

Contribution of Pantarhei Bioscience to the Congress of the European Society of Gynecology (ESG), 18-21 October, 2017 in Barcelona by an invited lecture of Herjan Coelingh Bennink

Symposium on Sexuality / Women’s Sexual Dysfunction Friday October 20, 2017 Chairpersons: Ali Kubba and Josep Perello Programme: Rossella E. Nappi: Sexual symptoms at menopause: are they all women’s dysfunction? Johannes Bitzer: Sexual health care for cancer patients. Rik HW van Lunsen: The Amsterdam multifacettel approach of sexual pain disorders aiming at restoring sexual pleasure. Herjan J.T. Coelingh Bennink: Improvement of sexual function during pill use by normalising free testosterone levels. For more information please […]
25th May 2017

11th Congress of the European Menopause and Andropause Society, May 22-24, 2017, Amsterdam, the Netherlands

On Wednesday May 24, 2017 Pantarhei sponsored a symposium entitled “Estrogens for breast- and prostate cancer treatment”. Lectures were presented by Herjan Coelingh Bennink (High dose estrogens for breast cancer), Carole Verhoeven (Estetrol for breast cancer) and Yvette Zimmerman (Estetrol for prostate cancer). The session was chaired by Ludwig Kiesel and Cobi Reisman.
6th April 2017

ENDO 2017, April 1-4, 2017 Orlando, USA, Press Release

The first weekend of April, Yvette Zimmerman, COO and Ellen Dutman, CRA at Pantarhei attended the ENDO congress in Orlando, USA, which is organised by the Endocrine Society. The results from a clinical study with estetrol in healthy men were presented in a poster session. For more information please read the press release of the Endocrine Society.
6th March 2017

BioCapital Europe conference March 15, 2017, Amsterdam, the Netherlands

The CEO of Pantarhei, Herjan Coelingh Bennink, will be presenting at the BioCapital Europe Conference on March 15, 2017 in Amsterdam. An ideal opportunity to meet us and discuss possibilities to collaborate, partner with or invest in Pantarhei’s programmes.